Subcutaneous Emphysema: Clinical Trials

1 trial for Subcutaneous Emphysema, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1

Follow Subcutaneous Emphysema: new trials by email Literature Review of Subcutaneous Emphysema trials Research Report on Subcutaneous Emphysema

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of BMN 349 Single Dose in PiZZ and PiMZ/MASH Adult Participants
BMN 349, Placebo - Alpha 1-Antitrypsin Deficiency
Phase 1Active not recruitingBioMarin Pharmaceutical62025-02-212026-05-06

Narrower conditions

alpha 1-Antitrypsin Deficiency (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Emphysema (1)  ·  Genetic Diseases, Inborn (1)  ·  Liver Diseases (1)  ·  Lung Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Respiratory Tract Diseases (1)

Sponsors

BioMarin Pharmaceutical (1)

Countries

United Kingdom (1)  ·  United States (1)